Role of Mitogen-activated Kinases in Cd40-mediated T Cell Activation of Monocyte/macrophage and Vascular Smooth Muscle Cell Cytokine/chemokine Production by Milhorn, Denise M.
East Tennessee State University
Digital Commons @ East
Tennessee State University
Electronic Theses and Dissertations Student Works
August 1999
Role of Mitogen-activated Kinases in
Cd40-mediated T Cell Activation of Monocyte/
macrophage and Vascular Smooth Muscle Cell
Cytokine/chemokine Production
Denise M. Milhorn
East Tennessee State University
Follow this and additional works at: https://dc.etsu.edu/etd
Part of the Immunology and Infectious Disease Commons
This Dissertation - Open Access is brought to you for free and open access by the Student Works at Digital Commons @ East Tennessee State
University. It has been accepted for inclusion in Electronic Theses and Dissertations by an authorized administrator of Digital Commons @ East
Tennessee State University. For more information, please contact digilib@etsu.edu.
Recommended Citation
Milhorn, Denise M., "Role of Mitogen-activated Kinases in Cd40-mediated T Cell Activation of Monocyte/macrophage and Vascular
Smooth Muscle Cell Cytokine/chemokine Production" (1999). Electronic Theses and Dissertations. Paper 2950. https://dc.etsu.edu/
etd/2950
INFORMATION TO USERS
This manuscript has been reproduced from the microfilm master. UMI films the 
text directly from the original or copy submitted. Thus, some thesis and 
dissertation copies are in typewriter face, while others may be from any type of 
computer printer.
The quality of this reproduction is dependent upon the quaiity of the copy 
submitted. Broken or indistinct print, colored or poor quality illustrations arxf 
photographs, print bleedthrough. sutwtandard margins, and improper alignment 
can adversely affect reproduction.
In the unlikely event that the author did not send UMI a  complete m anuscrit and 
there are missing pages, these wiH be noted. Also, if unauthorized copyrigfit 
material had to t>e rerrwved, a note wiH indicate the deletion.
Oversize materials (e.g., maps, drawings, charts) are reproduced t»y sectioning 
the original, beginning at the upper left-hand comer and continuing from left to 
right in equal sections with small overlaps.
Photographs included in the original manuscript have been reproduced 
xerographically in this copy. Higher quality 6” x 9” t>lack and white photographic 
prints are available for any photographs or illustrations appearing in this copy for 
an additional charge. Contact UMI directly to order.
Bell & Howell Information and Learning 
300 North ZSeb Road, Ann Arbor, Ml 48106-1346 USA
U N O
800-521-0600
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
ROLE OF MITOGEN ACTIVATED KINASES IN CD40-MEDIATED T CELL 
ACTIVATION OF MONOCYTE/MACROPHAGE AND VASCULAR SMOOTH 
MUSCLE CELL CYTOHNE/CHEMOKINE PRODUCTION
A Dissertation 
Presented to
the Faculty o f the Department of Biochemistry and Molecular Biology 
James H. Quillen College of Medicine 
East Tennessee State University
In Partial Fulfillment 
of the Requirements for the Degree 
Doctor of Philosophy in Biomedical Sciences
by
Denise M Milhom 
August 1999
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
UMI Number 9954846
UMI*
UMI Microform9954846 
Copyright 2000 by Bell & Howell Information and Learning Company. 
All rights reserved. This microform edition is protected against 
unauthorized copying under Title 17, United States Code.
Bell & Howell Information and Leaming Company 
300 North Zeeb Road 
P.O. Box 1346 
Ann Arbor, Ml 48106-1346
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
APPROVAL 
This is to certify that the Graduate Committee of 
Denise Marie Milhom 
met on the 
Twenty-fifth of June, 1999
The committee read and examined her dissertation^ supervised her defense of it in an 
oral examination, and decided to recommend that her study be submitted to the 
Graduate Council in partial fulfillment of the requirements for the degree of Doctor of 
Philosophy in Biomedical Sciences.
Signed on behalf of 
the Graduate Council
k //{
Graduate Committee
mm
u
Dean, School oflGraduate Studies
u
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
ABSTRACT
ROLE OF MITOGEN ACTIVATED KINASES IN CD40-MEDIATED T CELL 
ACTIVATION OF MONOCYTE/MACROPHAGE AND VASCULAR SMOOTH 
MUSCLE CELL CYTOKINE/CHEMOKINE PRODUCTION
by
Denise M. Milhom
Atherogenesis is characterized by the infiltration of immune competent cells such as 
monocytes/macrophages and T cells to the site of lesion formation, resembling a 
chronic inflammatory response. Histological studies have shown the T cells present at 
these lesions are activated, CD 154^, CD4^ T cells of the Thl or inflammatory 
phenotype. The presence of these cells may be critical in regulating vascular 
inflammation due to their capacity to activate proinflammatory activities in CD40^ cells 
in the vasculature including monocytes/macrophages and vascular smooth muscle cells 
(SMC), through the CD40:CD1S4 receptor ligand interaction. This dissertation 
represents efforts to determine the functional consequences acquired by SMC in 
response to CD40 ligation by activated CD 154^ T cells, and to elucidate components of 
the signaling pathway(s) activated in response to CD40 signaling in both monocytes and 
SMC.
To study the consequences of CD40 stimulation, primary human monocytes and aortic 
SMC were treated with plasma membranes purified from CD 154*, CD4* T cells. The 
ability of CD40 signaling to initiate cytokine/chemokine mRNA and protein synthesis 
was assayed by RNAse protection assay, and enzyme linked immuosorbent assay 
(ELISA), respectively. Western blot analysis was used to determine the activation state 
of members of the mitogen activated protein kinase (MAPK) family following CD40 
stimulation. In addition, the activation of the transcription factor, NFkB, which has 
been demonstrated to contribute the the induction of cytokine/chemokine expression 
was analyzed by electromobility shift assay (EMSA). Analysis of SMC cell surface 
expression of receptors responsive to T cell ligands, and the analysis of CD40-mediated 
regulation of SMC adhesion and co-stimulatory molecules was analyzed by flow 
cytometry.
The results presented in this dissertation demonstrate that SMC, like
monocytes/macrophages, are capable of interacting with T cells in a manner that results
in reciprocal activation events. SMC were shown to present antigen to, and activate T
iii
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cells. In turn T cell stimulus resulted in the activation of proinflammatory function in 
SMC initiated through the CD154:CD40 interaction. CD40 stimulation of SMC 
resulted in the production of the chemokines interleukin 8 (EL-8) and macrophage 
chemotactic protein-1 (MCP-1), and the upregulation of intercellular adhesion molecule 
(ICAM). Examination of the intracellular signaling pathways activated through CD40 
signaling revealed the involvement of MAPKs in the pathway leading to induction of 
proinflammatory activity. Evaluation of CD40 signaling in monocytes demonstrated 
the activation of the MAPK flunily members ERKl/2, but not the MAPK family 
members p38 or c-jun-N-terminal kinase (INK). In contrast, CD40 signaling in SMC 
was shown to result in ERKl/2 and p38 activation, and both of these kinases were 
shown to play a critical role in the induction of chemokine synthesis. An examination 
of the ability of anti-inflammatory (tytokines to modulate CD40 signaling in monocytes 
and SMC demonstrated that the anti-inflammatory cytokines IL-4 and IL-10 abrogate 
CD40-mediated induction of inflammatory cytokine production by monocytes. This 
inhibition was shown to be a result of a negative influence of IL-4 and IL-10 on CD40 
mediated ERKl/2 activation in monocytes. However, IL-4 and IL-10 did not inhibit 
SMC proinflammatory responses indicating a difference in the intracellular responses to 
these cytokines by the two cell types.
These studies contribute to the understanding of the interaction between SMC and 
CD4* T cells through the receptor:ligand pair CD40:CD154, and its role in the 
maintenance of vascular inflammation The identification of the signaling components 
of the monocyte and SMC CD40 signaling pathways will identify control points that 
may serve as targets for anti-inflammatory therapies.
IV
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CHAPTER 1 
INTRODUCTION
Cell Interactions and the Role of Cvtoldnes and Chemokines in Atherosclerosis 
Atherogenesis is characterized by the infiltration of immune competent cells, such 
as monocytes/macrophages and T lymphocytes at the site of a vascular lesion 
resembling a chronic inflammatory response. Tissue sections of atherosclerotic plaques 
have revealed that the T lymphocytes at the site of the vascular lesion are activated,
CD 154*, CD4*T helper cells of the Thl or inflammatory phenotype (Mach and others 
1998). These activated T cells may interact with cells in the vasculature through the 
receptor-ligand interaction of CD 154, expressed on activated T cells with its receptor 
CD40 expressed on a diverse group of cells including smooth muscle cells and 
monocytes/macrophages (Figure 1). This interaction has been shown to result in the up 
regulation of costimulatory and adhesion molecule expression, and the induction of 
inflammatory cytokine and chemokine synthesis in monocytes, and may result in similar 
functional consequences in SMC. We hypothesize that the interaction between 
activated T cells and monocytes, and activated T cells and SMC through the receptor- 
ligand pair CD40:CD154 results in inflammatory cytokine and chemokine synthesis 
contributing to the pathogenesis of atherosclerosis.
The presence of activated CD4* T cells at atherosclerotic lesions has been well 
established (Mach and others 1998). However the role of T cells in the maintenance
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
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Figure 1. Overview of CeilrCeil Interactions Occurring in Vascular Inflammation. A 
cross-sectional view of an artery illustrating cellzcell interactions which may be 
occurring through the receptor-ligand pair CD40:CD154 during atherogenesis.
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and/or exacerbation of atherosclerosis has not been elucidated. Research thus far has 
indicated that T cells appear early in the onset of atherosclerosis and localize to the site 
of insult or injury to the artery. T cells transmigrate through the endothelium from the 
media to the intima of the aorta where they have the ability to interact with many cells 
in the vasculature through the receptor-ligand pair CD1S4:CD40. Recently there has 
been increasing amounts of evidence that support a critical role of T cells in regulating 
vascular inflammation or atherosclerosis (Mach and others 1998). Treatment with 
antibodies against murine CD 154 limits atherosclerosis in susceptible mice, and the 
atheroma of mice treated with anti-CD 154 antibodies contains significantly fewer 
immune competent cells suggesting the involvement of inflammatory pathways and a 
role for CD40 signaling in atherosclerosis (Mach and others 1998). Additionally, T 
cells have the capacity to produce growth frctors such as basic fibroblast growth factor 
(bFGF) and heparin binding epidermal growth factor (HB-EGF) which are potent 
mitogens for SMC proliferation (Rolfe and others 1995), and several cytokines 
including IFNy, a known co-stimulus for macrophage activation, which enhances 
macrophage efrector function and induces or enhances MHC class H expression by 
many cells including macrophages, endothelial cells and SMC.
Smooth muscle cells and monocytes/macrophages are thought to play a crucial role 
in the process of atherogenesis. Both monocytes/macrophages and SMC have the 
propensity to become lipid-laden foam cells which contribute to the formation of the 
atherosclerotic plaque. Additionally, monocytes/macrophages and SMC may amplify 
the inflammatory process resulting in atherosclerosis due to their ability to express
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
class n  histoconqiatibility (MHC class ü) (Warner and Libby 1989). Class H 
expression in atherosclerotic lesions in vivo has been well documented (Hansson and 
others 1986) suggesting that antigen presentation may be occurring at atherosclerotic 
lesions resulting in the activation of T cells. Antigens present in atherosclerotic plaques 
may include modified lipoproteins, neoantigens revealed through tissue destruction and 
determinants arising from infectious agents (Libby and Hansson 1991). Furthermore, 
monocytes/macrophages and SMC have been shown to express CD40 which can 
interact with CD 154 present on activated T cells. Recent research has shown that 
ligation of CD40 on atheroma-associated cells (i.e. monocytes/macrophages and SMC) 
in vitro activates fimctional attributes such as the production of cytokines, chemokines, 
and adhesion molecules which are some of the critical components required for the 
directional migration of leukocytes during inflammatory processes. The inflammatory 
cytokines, tumor necrosis factor (TNF) a  and IL-1 p are both know to be involved in 
inflammatory diseases and are produced by several cell types including 
monocytes/macrophages and SMC. Interleukin (IL)-8 and monocyte chemotactic 
protein-1 (MCP-1) are well characterized members of the C-X-C and C-C chemokine 
subfamilies, respectively (Beasley and others 1995), are pro-inflammatory in nature, 
and are produced by several cell types including vascular smooth muscle cells and 
monocytes/macrophages. Histological studies have demonstrated these inflammatory 
cytokines and chemokines to be present in atherosclerotic plaques, suggesting that they 
may play a crucial role in the development, maintenance, and pathogenesis of 
atherogenesis by promoting the directed migration of inflammatory cells (Warner and
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
Libby 1989; Wang and others 1998; Liu and others 1997; Terkeltaub and others 1998). 
MCP-1 mRNA has been detected in several cells including macrophages, endothelial 
cells and SMCs in atherosclerotic arteries of patients undergoing a bypass 
revascularization (Seino and others 1995). Recent reports have shown that mice 
deficient in MCP-1 that were fed a high cholesterol diet deposited less lipids and had 
fewer macrophages present within their aortic walls as compared to the wildtype control 
(Boring and others 1998). Similarly, mice deficient in the MCP-1 receptor, CCR-2, 
had a overall decrease in atherosclerotic lesion size, and had significantly fewer 
macrophages and monocytes present in the aortas as compared to the wildtype control 
(Gu and others 1998). IL-8 is chemotactic for several cell types including T cells and 
neutrophils at picomolar and nanomolar concentrations respectively (Banka and others 
1991), and may be involved in the recruitment of T cells to the intima of a blood vessel 
contributing to the pathogenesis of atherosclerosis (Larsen and others 1989).
Structure and Function of CD40 
CD40 is a transmembrane glycoprotein of approximately 45kDa, a member of the 
tumor necrosis receptor superfamily, which also includes the TNF receptor (TNFRl 
and TNFR2), nerve growth factor receptor, and Fas (CD95). CD40 is expressed by a 
variety of cell types including B cells (Clark 1990), monocytes/macrophages (Alderson 
and others 1993), dendritic cells (Caux and others 1994), thymic epithelial cells (Galy 
and Spits 1992), endothelial cells (Yellin and others 1995), kératinocytes (Peguet- 
Navarro and others 1996), and smooth muscle cells (Mach and others 1998). CD40
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
interacts with its ligand, CD 154, a type H membrane protein of approximately 39 kDa, 
and a member of the TNF superfamily. CD 154 is preferentially expressed on 
activated, but not resting T cells (Lynch and Ceredig 1989; Nbelle and Snow 1992). 
Engagement of CD40 by its ligand CD154 has been reported to induce functional 
changes on these cell types that may contribute to inflammatory responses, including 
the secretion of pro-inflammatory (tytokines and chemokines, the up-regulation of 
costimulatory and adhesion molecules (Stout and Suttles 1996), and eflects on cellular 
proliferation (Yellin and others 1995). CD40 and its receptor CD 154 has been 
identified as a receptor:ligand pair which œntributes to contact dependent signaling 
between monocytes and T cells. The importance of CD 154 in vivo was revealed by 
studies of X-linked Hyper-IgM Syndrome patients,. Hyper-IgM Syndrome is an 
immuncxleficiency characterized by the absence of circulating IgA and IgG and the 
absence of germinal centers, which is a result of defects in the gene encxxling CD 154 
(Klein and Miedema 1995). CD40 was initially identified on the surface of B cells 
Banchereau and others 1994) where CD40 signaling provides critical costimulatory 
signals required for proliferation, isotype switching, germinal center formation, and the 
generation of memory B cells (Grabstein and others 1993). The signaling pathways 
activated through CD40 in B cælls involve activation of the src family PTK’s, PKC, 
Jak3, serine/theonine kinases, MAPK family members (JNK, p38 and ERKl/2) and 
PLCy2 (Aagaard-Tillery and Jelinek 1996; Padmore and others 1997; Hanissian and 
Geha 1997).
In monocytes/macrophages, CD40 ligation has been shown to induce monocyte-
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
derived inflammatory cytokine synthesis (Wagner and others 1994), nitric oxide 
production (Stout and others 1996), and to rescue monocytes from undergoing 
apoptosis (programmed cell death) induced by the deprivation of serum factors (Suttles 
and others 1996). Additionally, our laboratory has demonstrated that CD40-mediated 
rescue from apoptosis is critically dependent on the activation of PTK but does not 
appear to involve the serine/threonine kinase PKC family (Suttles and others 1996).
Our laboratory has also observed activation of the transcription factor Nuclear Factor- 
kappa B (NF-kB) in response to CD40 signaling in monocytes. NF-kB is a 
transcription frctor involved in the transcription of several genes. It is present in the 
cytosol in an inactive state, complexed with the inhibitory I kappa B (IkB) proteins 
(Baeuerle and Baltimore 1988; Beg and others 1993; Finco and others 1994).
Activation of NF-kB occurs through phosphorylation of iKB-a at serine 32 and 36, 
resulting in the release and nuclear translocation of active NF-kB where it can bind 
relevant gene promotors (Brown and others 1995; Brockman and others 1995; Chen 
and others 1996). The release of active NF-kB results from the phosphorylated IkB 
conjugating with ubiquitin followed by proteaosome-mediated degradation of IkB (Chen 
and others 1996).
CD40 does not contain cytoplasmic sequences with catalytic activity and has been 
shown to signal through cytoplasmic adaptor proteins of the TNF receptor-associated 
factor family (TRAF), which activate intracellular signaling pathways (Dadgostar and 
Cheng 1998). All TRAF family members contain homologous C-terminal TRAF 
domains, TRAFs 2 through 6 contain an N-terminal ring finger and zinc finger-like
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
8domains (Dadgostar and Cheng 1998), and TRAF 3 and TRAF 5 contain an isoleucine 
zipper domain (Cheng and others 1995; Ishida and others 1996; Nakano and others 
1996). TRAFs 2, 5 and 6 interaction with CD40 has been associated with activation of 
the transcription frctor NF-kB (Ishida and others 1996), however the disruption of 
CD40 cytoplasmic sequences involved in TRAF interaction does not eliminate 
NF-kB activation (Using and others 1997). Additionally, signalmg through CD40 can 
initiate TRAF mediated activation of MAPK family members (Natoli and others 1997), 
however the role of the TRAF family members in CD40-mediated activation of 
monocytes/macrophages and SMCs has not been investigated.
Previous research in our laboratory has demonstrated modulation of CD40-mediated 
monocyte inflammatory cytokine synthesis by the Th2-derived anti-inflammatory 
cytokines IL-4 and IL-10 (Poe and others 1998). Several studies have shown inhibition 
of monocyte/macrophage inflammatory function in response to lipopolysaccharride 
(LPS) (Moore and others 1993). In vivo, it has been shown that these cytokines reduce 
autoimmune inflammatory diseases, and IL-10 is being used in clinical trials to treat 
autoimmune diseases (Horsfall and others 1997; Narula and others 1998). The 
mechanism by which IL-4 and IL-10 inhibit inflammatory cytokine synthesis has not 
been elucidated, however previous research in our laboratory suggested that the 
effectiveness of these cytokines may result from the inhibition of the signaling 
pathway(s) activated in response to CD40 ligation in monocytes. Our laboratory has 
recently shown that IL-4 and IL-10 act early in the CD40 signaling cascade by 
modulating the overall PTK induction in monocytes.
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Both IL-4 and IL-10 signal through receptors which associate with and activate the 
Janus family (Jak) tyrosine kinases upon ligation (O’Shea 1997; Leonard and O’Shea 
1998). The Jaks in turn, activate proteins called Signal Transducers and Activators of 
Transcription (Stats). The Stats translocate to the nucleus where they regulate the 
expression of various genes (Darnell 1997) (Figure 2). The Stats are inducers of a 
family of negative regulators of (tytokine signalmg, the suppressor of (tytokine signals 
(SOCS) which work as a negative feedback system to inhibit the Jaks either directly or 
non-directly (Nicholson and Hilton 1998). CD40-mediated activation of the Jaks in 
monocytes has not been investigated, however in B cells studies have shown that CD40 
may associate with Jak3 (Hanissian and Geha 1997). The data thus far indicate that IL- 
4 and IL-10 inhibit the early PTK activity initiated from CD40 ligation suggesting that 
EL-4 and IL-10 may induce protein tyrosine phosphatase (FTP) activity, resulting in the 
suppression of the CD40 signaling pathway in monocytes, and thus suppression of 
ERKl/2 activity.
MAPK Signaling
The mitogen-activated protein kinases (MAPK) family members are a group of 
protein serine/threonine kinases that are activated in response to a variety of 
extracellular stimuli and regulate a number of cellular responses. Along with other 
signaling pathways, the MAPK hunily members mediate signal transduction by 
differentially altering the phosphorylation status of transcription factors (Sivaraman and 
others 1997; Das and Vonderhaar 1996; Tong and other 1997) (Figure 3). There are
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
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Figure 2. Jak/Stat Signaling Cascade
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Figure 3. The ERKl/2, JNK, and p38 MAPK Signaling Cascades. The inhibitor 
PD980S9 inhibits Raf-1 phosphorylation of MEKl/2, and therefore the phosphorylation 
of ERKl/2. The inhibitor SB203S80 inhibits phosphorylation of p38 MAPK.
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three members of the MAPK family; extracellular signal regulated kinase (ERKl/2), c- 
Jun-N-terminal kinase (JNtQ and p38. The ERKl/2 signaling cascade involves the 
activation of receptor tyrosine kinases (which have src homology) which provide the 
binding site for the adaptor protein, growth receptor-bound protein 2 (GRB2), which 
localizes the guanine nucleotide exchange Actor, son of sevenless (SOS), to the plasma 
membrane. SOS activates Ras by exchange of GTP for GDP (Winston and Hunter 
1996; Sagata 1997; Takeuchi and others 1999; Hildt and Oess 1999). The Ras-GTP 
activated Raf phosphorylates a dual specificiQr kinase MAPK/ERK kinasel/2 
(MEKl/2), which is phosphorylated on serine 218 and 222 (Avruch and others 1994). 
Active MEKl/2 dually phosphorylates ERKl/2 on theonine 183 and Qrrosine 185 
(Burack and Sturgill 1997; Cobb and others 1996). Active ERK translocates to the 
nucleus to phosphorylated a variety of transcription factors including Elk-1 (Gille and 
others 1992; Cheng and others 1996), C/EBPp (NF-IL-6) (Nakajima and others 1993), 
ATF-2 (Abdel-Hafiz and others 1992), and NF-kB (Dadgostar and Cheng 1998).
The INK signaling pathway is activated in several ways including exposure to UV 
radiation, heat shock, or inflammatory cytokines (Su and Karin 1996; Hibi and others
1993) and is mediated by Rac and cdc42, two small GTP binding proteins (Davis
1994). Activated cdc42 binds to PAK65 which activates MEK kinase (MEKK-1). 
MEKK-1 phosphorylates MEKK-4 at serine 219 and serine 223. The active MEKK-4 
phosphorylates JNK which translocates to the nucleus and activates a variety of 
transcription factors including c-Jun (Kyriakis and others 1994; Derijard and others
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
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1995), ATF-2 (Gupta and others 1995) and Elk-1 (Cavigelli and others 1995).
The p38 MAPK Amily member is activated in response to several stimuli including 
inflammatory cytokines, endotoxins and osmotic stress (Tong and others 1997; Han and 
others 1994; Rouse and others 1994). P38 is activated by MEK kinase kinase-3 
(MKK3) a dual specificity kinase. Following phosphorylation p38 translocates to the 
nucleus and phosphorylates and activates transcription Actors including ATF-1, CREB 
(Tan and others 1996), Elk-1 (Price and others 1996), CHOP (Wang and Ron 1996), 
and ATF-2 (Raingeaud and others 1996).
The sites of phophorylation are conserved between the MAPK family 
members, however, these sites are located within distinct dual specificity 
phosphorylation motifs; TEY for ERK, TPY for JNK, and TGY for p38 (Davis 1994; 
Derijard and others 1994; Raingeand and others 1995). Additionally, the MAPK 
family members share sequence homology -45% sequence homology between JNK and 
ERK (Moriguchi and others 1996), and -50% homology between p38 and ERK (Tong 
and others 1997) .
This dissertation represents the results of studies designed to evaluate the role of 
CD40 signaling in two key cells found at atherosclerotic lesions, SMC and 
monocytes/macrophages, which contribute to the maintenance and/or exacerbation of 
vascular inflammation. We investigated the functional activities expressed by SMC in 
response to CD40 ligation, and critical components involved in CD40-mediated SMC 
chemokine synthesis. Additionally we examined the role of MAPK family members in 
CD40-mediated synthesis of inflammatory cytokines and chemokines in
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monocytes/macrophages and SMC. and evaluate the role of anti-inflammatory qrtokines 
on CD40-mediated activation of ERKl/2 MAPK family member(s), a critical 
component in CD40-mediated induction of mono<yte IL-ip and TNFa synthesis in 
monocytes and IL-8 and MCP-1 synthesis in SMC. Gaining a better understanding of 
CD40-mediated activation of specific kinases, transcription Actors and inflammatory 
cytokines and chemokines, and how these events can be modulated by natural medAtors 
will help identify potential targets for drug intervention.
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MATERIALS AND METHODS
Control o f  endotoxin contamination
All cell culture reagents used were either certified as low endotoxin when 
purchased, or were ensured low endotoxin as determined by chromogenic limulus assay 
(BioWhittaker, Walkersville, MD). Stock solutions containing >  1 ng/ml (10 
endotoxin units/ml) were considered unacceptable. Stock solutions were diluted in 
assays such that endotoxin levels did not exceed 1 pg/ml.
Inhibitors/ Reagents
The MEK1/MEK2 inhibitor PD98050 was obtained firom New England BioLabs, 
Inc. (Beverly, MA). The p38 MAPK inhibitor SB203580, the PTK inhibitor 
Herbimycin A and the PKC inhibitor RO-31-75499 were purchased from Calbiochem 
(La Jolla, CA). H7 was purchased from Sigma Chemical Co. (St, Louis, MO). IL-4 
and IL-10 were purchased from R&D Systems (Minneapolis, MN). Sodium 
orthovanadate (Na^VOJ was acquired from Fisher Scientific, (Fair Lawn, NJ).
Antibodies
The following mAB's were prepared form culture supernatants of hybridomas 
purchased form American Type Culture Collection (ATCC, Rockville, MD): IgG
15
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mouse anti-human CD3 (OKT-3), IgG mouse anti-human CD8 (OKT-8), IgG mouse 
anti-human monocyte (3C10), IgG mouse anti-human B cell (LYM-1), IgM mouse anti­
human NK cell (hNK-1), and IgG mouse anti-human CD40 (G28-5). BioMag* goat 
anti-human IgG and IgM was obtained from PerSeptive Diagnostics, Inc. (Cambridge, 
MA). FITC-conjugated donkey anti-mouse IgG (H + L) was purchased from Jackson 
Immunoresearch Laboratories, Inc. (West Grove, PA). IgG mouse anti-human CD154 
mAh was obtained from Genzyme (Cambridge, MA). Rabbit antibodies recognizing 
the active, phosphorylated (Thr‘“ , Tyr‘“ ) form of ERKl/2 were acquired from 
Promega (Madison, WI) and New England BioLabs. Rabbit antibodies recognizing 
phosphorylated p38 (Thr‘“ , Tyr‘“ ) and phosphorylated JNK (Thr^“ , Tjrr*“ ) were 
purchased from New England BioLabs. Horseradish peroxidase-conjugated F(ab')2 
donkey anti-rabbit AB was purchased form Jackson ImmimoResearch Laboratories 
(West Grove, PA). Monoclonal mouse anti-human CD 154 was prepared from culture 
supernatant of the hybridoma 5C8 (American Type Culture Collection, Rockville,
MD). The monoclonal mouse IgG anti-human CD40 used for flow cytometry was 
prepared from culture supernatant of the hybridoma G28-5 (American Type Culture 
Collection, Rockville, MD). The FITC-conjugated donkey anti-mouse IgG (H 4- L) 
was purchased from Jackson Immunoresearch Laboratories, Inc. (West Grove, PA).
Cell Lines
Cell lines used in these studies included 293 (human embryonic kidney, ATTC), 
stable transfectants of 293 which express high levels of CD154 (Yellin and others 
1994), the human T cell leukemia line Jurkat (ATCC) and the CD 154^ subclone of
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Jurkat, D l.l (Yellin and others 1991). Both D l.l and 293-CD154 transfectants were 
gifts of Dr. Seth Lederman, ColumbA Universify. Cell lines were maintained in RPMI 
1640 (Hyclone, Logan, UT), containing l(X)mM HEPES, SO pg/ml gentamicin, and 
5 % fetal bovine serum (FBS) (R-5). The 293-CD154 transfectants (created by co­
transfection with pcDNA 1-CD154 and pRSVneo) were periodically passaged in 200 
pM G418 (Gibco/BRL). The hiunan aortic smooth muscle cell line (SMC) was 
obtained from Clonetics Corporation (San Diego, CA). The SMC line designated 
AOSMC 2634-3 by Clonetics, was characterized phenotypically as SMC and found to 
be virus-free. The line was maintained in SmGM*-3 BuUetKit* (Clonetics) containing 
0.5pg/ml human recombinant Epidermal Growth Factor, 5mg/ml Insulin, 1 pg/ml 
human recombinant Fibroblast Growth Factor, 50mg/ml Gentamicin, and 2% FBS 
(Clonetics Corporation). The SMC cell line was rested in Human Endothelial-SFM* 
Gibco/Life Technologies, Grand Island, NY). SMC were cultured in 25cm tissue 
culture flasks (Coming, Incorporated, Coming NY).
CD4^ T cell Purification and Activation 
CD4^ T cells were purified by negative magnetic panning from elutriation-enriched 
T cell populations. Cells were incubated in R-5 with mAB's against cell surface 
molecules generated from the hybridomas OKT-8 (anti-CD8^ T cell), 3C10 (anti­
monocyte), LYM-1 (anti-B cell), and hNK-1 (anti-NK cell), used as culture 
supematants at dilutions of 1:10, for 30 min at RT. Cells were then treated with 
BioMag® iron-conjugated antibodies to murine IgG and IgM (PerSeptives Diagnostics,
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Cambridge, MA) for 30 min with gentle shaking at 4°C. Cells were diluted with DPBS 
in 75 cm  ^flasks (Fisher Scientific) and the CD4 populations were removed via 27 
megagauss Oerstead magnets (PerSeptives DAgnostics). A sample of the purified 
population was stained with an FITC conjugated anti-CD4 mAh and analyzed by flow 
cytometry on a FACSTAR* flow cytometer (Becton Dickinson, San Jose, CA). 
Resulting populations were typically found to be greater than 95% CD4 . CD4^ T 
cells were then rested in R-5 alone, or activated for 6 h in R-5 by mcubation with 
lOng/ml phorbol myristic acetate (PMA) (Sigma) and 0.5pM ionomycm (Calbiochem, 
San Diego, CA). Expression of CD 154 on activated, but not restmg, CD4^ T cells was 
then confirmed by flow cytometric analysis on a FACSTAR* plus flow cytometer 
(Becton Dickinson).
Monocvte Isolation and Culture 
Blood was collected from normal, healthy human volunteers and PBMC's were 
isolated over a Ficoll densify gradient (Fico-Lite-LymphoH, Atlanta Biologicals, 
Norcross, GA). PBMC's were plated at a density of 5 x 10® cells/well in 24-well tissue 
culture plates (Falcon Primaria, Lmcoln Park, NJ) in RPMI 1640 (Hyclone,
Logan, UT), containing 100 mM HEPES, 50 pg/ml gentamicin, and 5% FBS (R-5). 
Monocytes were isolated by plastic adherence for 1 h at 37 °C after which nonadherent 
cells were removed by Pasteur pipetting during 2 washes with Dulbecco's PBS (DPBS). 
Cells were maintained in R-5 overnight prior to treatment.
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T-Cell Plasma Membrane Preparation 
For the preparation of purified plasma membranes, resting and activated purified 
CD4^ T cells were resuspended in a hypotonic buffer containing SO mM Tris-HCL, pH 
7.4, 25 mM KCl, 5 mM MgClz, and 50 pg/ml phenolmethylsulfonyl fluoride (PMSF) 
for 30 min on ice. The cells were then homogenized using a PowerGen 35 
homogenizer (Fisher Scientific) until completely disrupted as determined 
microscopically. Disrupted cells were centrifuged at 500 x g for 5 min to remove 
nuclei, then centrifuged at 95,(X)0 x g for 30 min using a Ti-50 rotor in a Beckman L5- 
65 Ultracentrifuge. Cell debris was resuspended in 35% (wt/vol) sucrose/hypotonic 
buffer then layered on 73% (wt/vol) sucrose/hypotonic buffer. Hypotonic buffer was 
layered on the 35% sucrose and the samples were centrifuged using a SW50.1 rotor at 
130,000 X g for 1 h to separate plasma membranes. The plasma membrane layer (at the 
73%-35% interface) was collected and diluted 1:5 with hypotonic buffer, then 
centrifuged again for Ih at 130,000 xg  to pellet purified plasma membranes. The 
membrane pellets were resuspended in PBS and total protein was determined by 
microtiter plate protocol of the bicinchoninic acid (BCA) protein assay (Pierce, 
Rockford, IL). The BCA protein assay was read on a Biotek Instruments microtiter 
plate reader at 561nm.
Flow Cvtometric Analvsis 
Smooth muscle cells were harvested from tissue culture flasks with .025% 
Trypsin/EDTA (Clonetics Corporation). SMC were labeled with the appropriate
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dilution of the primary antibody 30 min at room tenq>erature, washed in DPBS, and 
stained with a FITC-conjugated donkey anti-mouse IgG (H +  L) secondary antibody 
for 30 min at RT. Cells were washed in DPBS and analyzed for CD40, CD95 or 
ICAM surface expression on a FACSTAR* plus flow cytometer (Becton Dickinson, San 
Jose, CA).
Electrophoretic Mobility Shift Assay (EMSA)
After treatment or stimulation as required by the particular assay, cells were 
collected and lysed to isolate nuclei based on the method of Bturas and others (1994). 
Briefly, cells were lysed in hypotonic buffer containing 10 mM KCl, 0.3 M sucrose, 10 
mM P glycerol phosphate, 0.2 mM EDTA, 0.4% nonidet P-40, 1 mM PMSF and 1 
;fg/ml each of leupeptin and pepstatin, on ice for 30min with gentle agitation.
Following lysis, nuclei were collected by centrifugation at 11,500 x g for 5min.
Nuclear proteins were extracted by incubating nuclei in a buffer containing 25% 
glycerol, 0.3 M KCl, 1.5 mM MgCl;, 0.2 mM EDTA, 0.5 mM dithiothreitol, 1 mM 
PMSF, and 1 /tg/ml each of leupeptin and pepstatin for 30 min on ice. Extracts were 
centrifuged at 11,500 x g and supematants were collected as nuclear extracts. Protein 
determinations were performed by the BCA micro protein assay. Extracts were 
aliquoted and stored at -80° C. Binding assays were performed using a gelshift assay 
kit consensus oligonucleotide containing the binding element for NF-kB (Geneka, 
Quebec, Canada) that was end-labeled using ^P-gamma ATP (Amersham Pharmacia 
Biotech, Inc., Piscataway, NJ). Nuclear extracts were incubated with gel shift binding
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buffer and end-labeled oligonucleotide at approximately 5x10® cpm. Binding 
reactions were done per Geneka protocol. Following binding reactions, samples were 
analyzed on 5% polyacrylamide gels. Following electrophoresis, gels were dried onto 
Whatman filter paper and exposed to x-ray film fi-om several hours to overnight at 
room temperature. X-ray films were analyzed by scanning densitometry using the UN- 
SCAN-IT-gel automated digitizing system. Silk Scientific Corp., Orem, UT.
Western Blot Analvsis 
Prior to stimulation, monocytes were pretreated with 50#tM Na^ VO,* for 20 min to 
negate FTP effects on tyrosine-phosphorylated cellular proteins during stimulation. 
After monocyte or smooth muscle cell treatment/stimulation in 24-well plates, cells 
were lysed in 50 /xl boiling treatment buffer (125 mM Tris, pH 6.8, 2% SDS, 20% 
glycerol, 1% beta-mercaptoethanol, and 0.003% bromophenol blue) containing 1 mM 
each PMSF and sodium orthovanadate. Samples were boiled an additional 5 min prior 
to protein separation by SDS-PAGE on 15% minigels. Gels were equilibrated in 
transfer buffer (48 mM Tris, pH 9.2, 39 mM glycine, 1.3 mM SDS, and 20% 
methanol) for 15 min prior to transfer. Protein transfer to nitrocellulose membranes 
(Coming Costar Corp., Kennebunk, ME) was performed at 15V for 30 min using a 
Trans-Blot* SD Semi-Dry Electrophoretic Transfer Cell (Bio-Rad, Richmond, CA). 
Dried membranes were blocked by gentle agitation in PBS containing 0.1% Tween 20 
and 1 % BSA (blocking buffer) for 30min at 37° C. Membranes were incubated with
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the relevant primary Ab in blocking buffer for 30 min at 37° C, and then washed for 10 
min x2  washes in PBS containing 0.1% Tween 20 (wash buffer), followed by 
incubation with the relevant (HRP-conjugated) secondary Ab for 30 min at 37 °C (if 
primary antibody not HRP-conjugated), and then washed for 10 min x3 in wash 
buffer. Ab-bound proteins were detected using an ECL™ Western blotting analysis 
system (Amersham Corp.. Arlington Heights, IL) and the membranes were exposed to 
Kodak X-Omat LS X-ray film (Eastman Kodak, Rochester, NY). X-ray films were 
analyzed by scanning densitometry using the UN-SCAN-IT-gel automated digitizing 
system.
Analvsis of Chemokine Production 
Analysis of IL-8 and MCP-1 production by SMC stimulated through CD40, was 
examined by ELISA. SMC were plated in 96 well microtiter plates and rested for 10 
days in serum free medium. The cells were then treated with IFNy for 5 days to up- 
regulate CD40 expression. SMC were co-incubated with activated T cell membranes 
(TmA), resting T cell membranes (TmR), 293 parent cell line, 293-CD154 
transfectants, Jurkat cell line, or D l.l cells. Supematants were harvested after an 18-h 
incubation and assayed by enzyme-linked immunosorbant assay (ELISA) using R&D 
system’s Quantikine™ human enzyme linked immunosorbant assay system or OptEIA™ 
sets for human IL-8 and MCP-1, PharMingen (San Diego, CA).
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RNAse Protection Assay 
Following stimulation of SMC, cells were lysed and RNA was isolated using TRIzol* 
Reagent (Life Technologies/Gibco) per TRIzol* protocol. The Riboquant* Multi-Probe 
(PharMingen) RNAse protection assay system was used to detect mRNA species. The 
multi-probe was labeled with a-®^P-UTP (Amersham), and hybridized to the RNA. 
RNAse treatment and purification of protected probes was performed per Riboquant* 
protocol. Samples were analyzed on ()uickPoint™ precast gels (NOVEX, San Diego, 
CA), and exposed to Kodak X-Omat LS X-ray film.
Alloreactive Proliferation Assay 
A total of 4x10® SMC per well were plated in 96-well tissue culture plated in SMGM*- 
3, and lOOU/ml recombinant human IFNy was added after overnight culture. On day 
3, cultured cells were washed with PBS, and treated with SO ^g/ml mitomycin C 
(Sigma Chemical Co.) to ensure that they were unable to contribute to the 
measurement of [®H]-thymidine incorporation used to assay T cell proliferative 
responses. In some experiments, the SMC were fixed, with freshly prepared 0.8% 
paraformaldehyde at room temperature (RT) for 10 minutes, rather than mitomycin C- 
treated. The cells were washed with PBS prior to addition of 2x10* human CD4^ T 
cells per well with or without IL-1 (1% P388D1 supernatant) as a source of costimulus. 
Three days after addition of the T cells, the cells were pulsed with 0.5 /iCi/well 
[®H]thymidine for 3 h and harvested on glass fiber filters for scintillation counting.
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RESULTS
CD40 Signaling in Monocvtes
CD40 Activation of ERKl/2 in Monocvtes
Previous research done in our laboratory demonstrated that CD40-mediated 
monocyte inflammatory cytokine synthesis was dependent on activation of PTKs (Poe 
and others 1998). To further investigate the activation of PTKs, the role of MAPK 
family members in T cell activation of monocytes through CD40 signaling was 
evaluated. Stimulus was provided by purified plasma membranes from CD4^ T cells 
which had been activated for 6 hours (a time point at which CD 154 expression was 
optimal) designated TmA. Purified plasma membranes from resting (CD 154 ) T cells, 
designated TmR, were used as a control. Plasma membrane preparations were titrated 
for activity based on membrane protein concentrations. In the experiments presented in 
this dissertation, membranes were used at lOpg of protein/ml. The ability of TmA to 
induce MAPK phosphorylation was evaluated over a 2 hour time period postactivation. 
ERKl/2 phosphorylation was evident at 10 minutes, and declined at 2 hours (Figure 
4A, top panel). The blot was stripped and reprobed with antibody recognizing both 
phosphorylated and nonphosphorylated forms of ERK present demonstrating that the 
differences observed were not due to differences in the level of ERKl/2 protein, or 
artifacts of gel loading (Figure 4A, bottom panel).
24
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Figure 4. CD40-Mediated Activation of ERKl/2 m Monocytes. A, analysA of ERKl/2 
phosphorylation . Monocytes were left unstimulated or stimulated with LPS for 30 
minutes, or TmA for 10, 30, 60 or 120 minutes. After stimulation lysates were 
harvested and analyzed by western blot using an antibody specific for the 
phosphorylated form of ERKl/2 (top panel) or antibodies recognizing total ERKl/2 
(bottom panel). B, analysis of p38 and JNK phosphorylation. Monocytes were 
stimulated as in A, lysates were harvested and analyzed by western blot using 
antibodies specific for the phosphorylated forms of p38 and JNK.
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
26
Although LPS stimulation resulted in the activation of the MAPK family members p38 
and JNK, treatment of the monocytes over the same time period examined in 3A did not 
induce or enhance p38 or JNK phosphorylation (Figure 4B). These data suggested that 
CD40 signaling in monocytes resulted in the phosphorylation of the MAPK Amily 
member ERKl/2, but not in the phosphorylation of p38 or JNK over the time period 
examined (Suttles and others 1999).
IL-4 and IL-10 Inhibit CD40-Mediated Monocvte ERKl/2 Phosphorvlation
In previous work, IL-4 and IL-10 were found to inhibit CD40-induced activation of 
PTK activity and the subsequent synthesis of inflammatory cytokines (Poe and others 
1997). Additionally our previous work indicated a role of MEK and ERK activation in 
this pathway, therefore we hypothesized that IL-4 and IL-10 acted by interference of 
the signaling cascade leading to ERKl/2 activation. To test this hypothesis, monocytes 
were pretreated for an 18-h period with IL-4 or IL-10 prior to TmA stimulation and the 
cell lysates were assayed for phosphorylation of ERKl/2. ERKl/2 activation was 
decreased in a dose-dependent manner with both IL-4 and IL-10 (Figure S). 
Quantification by scanning densitometry indicated that a dose of 50 ng/ml IL-4 resulted 
in 79% decrease in the level of phosphorylation observed over background in response 
to TmA. A 90% decrease was observed with treatment of IL-10 at 50 ng/ml. Neither 
of these cytokines affected the level of expression of ERK’s during this time period as 
shown by Western blots of the same samples, reprobed with an antibody reactive with
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Figure 5. Effects of IL-4 and IL-10 on CD40-Mediated ERKl/2 Activation in 
Monocytes. Monocytes were pretreated with IL-4 or IL-10 at 5, 10, and 50 ng/ml, as 
indicated, then left unstimulated (control) or stimulated with TmA for 30 minutes. Cell 
lysates were harvested and analyzed by western blot for level of ERKl/2 
phosphorylation using anti-phospho-ERKl/2 antibodies (top panel). The film was 
scaimed and the digitized image analyzed for band density. The histogram represents 
density (total pixels minus background x 10 ^ ) of the ERK2 bands (middle panel). The 
membrane was stripped and reprobed using antibodies recognizing total ERK (bottom 
panel).
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total ERKl/2, which show equivalent levels of ERKl/2 regardless of treatment (Fig 
5,bottom panel).
Evidence of T Cell-SMC Interactions
SMC Express CD40
Monocytes can interact with activated CD4^ T cell through several receptorrligand 
pairs including the interaction of CD40 on monocytes with its natural ligand CD 154 
present on activated CD4^ T-cells. This interaction results in the up-regulation of pro- 
inflammatory cytokine synthesis. Both monocytes and SMC appear to play a role in 
vascular inflammation by interacting with T cells. We next examined SMC for CD40 
and other receptors which have the ability to interact with T cells similar to monocytezT 
cell interactions. Using the monocytezT cell model we hypothesized that vascular 
smooth muscle cells may interact in a similar way contributing to the development of 
vascular inflammation. To address the hypothesis we phenotyped the SMC to 
determine the expression of the cell surface molecule CD40. SMC were treated over a 
period of 0 to 5 days with Thl cytokine IFN-y, which is a costimulus for macrophage 
activation and has been shown to up-regulate MHC-II expression in other cell lines. 
Cells were harvested and stained with anti-CD40 antibodies and analyzed by flow 
cytometry for CD40 expression (Figure 6). Untreated cells were negative for CD40 
expression. However, IFNy treatment induced CD40 expression which increased over 
the five day period. The experiment was carried out through day 7
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Figure 6. IFNy Up-regulates CD40 Expression on SMC. A, CD40 surface expression 
on SMC. SMCs were left untreated or treated with lOOU/ml of IFNy for 3 days. Cells 
were harvested and stained for CD40 surface expression. Cells were analyzed by flow 
cytometric analysis. B, Kinetics of IFNy treated on CD40 surface expression on SMC. 
SMC were left untreated or treated with IFNy over time period of 1 to 5 days. Cells 
were harvested and analyzed by flow cytometric analysis.
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(data not shown), however, expression declined consistently after day 5.
SMC Express CD95
Monocytes can interact with activated T ceils through several receptorrligand pairs 
in addition to the CD40:CD1S4 interaction. Monocytes express CD95 (Fas), a 
member of the TNF receptor superAmily. CD95 binds to its ligand CD95L (Fas 
ligand) expressed on T cells. This interaction can lead to programed cell death or 
apoptosis. Apoptosis of SMC has been demonstrated in vivo and in vitro (Bennett and 
others 1995). Apoptosis of SMC observed in atheroma suggest that this process 
contributes to vascular remodeling that results in intimai thickening and fibrous cap 
formation. We hypothesized that SMC express CD95, which could interact with T cells 
through the CD95:CD95L receptorrligand interaction similar to the monocyte-T cell 
model, resulting in apoptosis, and vascular remodeling. To address this hypothesis, 
SMC were analyzed for CD95 expression by flow cytometry (Figure 7).
SMC Present Antigen to CD4^ T cells
Monocytes have the abiliQr to display peptide-MHC complexes in a form that can be 
recognized by T cells, and are known as classical antigen presenting cells (APC). The 
interaction of T cells with monocytes through antigen presentation results in reciprocal 
activation involving both contact-dependent and cytokine-mediated signals.
Since the possible SMC-T cell interactions seem to resemble the monocyte-T cell 
model, we were interested in exploring the possibiliQr of antigen presentation by SMC
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Figure 7. SMC Express CD95. Analysis of cell surface expression of CD95(Fas) on 
SMC. SMC were left untreated or treated with IFNy for 5 days. After 5 days of 
treatment the cells were were harvested, stained for sur&ce CD95, and analyzed by 
flow cytometric analysis.
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to T cells. Previous work done in the murine system has shown that pure populations 
of vascular smooth muscle cells (VSMC) clones are capable of antigen processing and 
presentation via the exogenous pathway to syngeneic or histocompatibili^ matched 
CD4^ T cells. We have hypothesized that human SMC are also capable of antigen 
presentation to allogeneic CD4^ T cells. To determine this human SMC were treated 
with lOOU/ml IFN-y for 3 days, which had been shown in previous experiments to 
optimally induce expression of class H MHC in monocytes. SMC were IFN-y primed 
for three days, washed with DPBS and treated with mitomycin C to ensure that the cells 
were unable to contribute to the measurement of [^H]-thymidine incorporation or fixed 
with 0.8% paraformaldehyde. The SMC were co-cultured with human allogeneic 
CD4^T cells in the presence or absence of IL-ip as a source of co-stimulus. On day 3 
of culture, wells were pulsed with [^H]-thymidine, and SMC were evaluated for their 
ability to activate the T cells by allo-antigen presentation. CD4^T cells incubated in the 
presence of fixed allogeneic SMC proliferated excessively as compared to the 
mitomycin C treated group (Figure 8). These data indicate that the SMC are capable of 
allo-antigen presentation to CD4^ T cells, and therefore reciprocal activation.
Influence of CD40 Signaling on SMC Chemokine Production
Our laboratory has demonstrated that CD40 signaling in monocytes results in the 
activation of inflammatory cytokine synthesis and rescue from apoptosis. We have also 
demonstrated that both of these events are critically dependent on the activation of PTK 
and but does not exhibit dependence on the activi^ of the PKC family (Poe and others
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Figure 8. Alio-Antigen Presentation to CD4^ T Cells by SMC. SMC were plated in 
96-well culture plates, IFNy treated, and either paraformaldehyde fixed or treated with 
mitomycin C. 10* allogeneic CD4^ T were added to the SMC cultures in the presence 
or absence of IL-ip (1%P388D1 supernatant). On the third day T cell proliferation 
was assayed by [*H]thymidine incorporation. The average cpm [*H]thymidine 
incorporation ±  standard deviation of triplicate samples.
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1997) However, the activi^ of PTK and the activity of the serine/threonine PKC 
family has been demonstrated in CD40 signaling in B cells. We were interested in 
determining the nature of kinase involvement in CD40 signaling in SMC. CD40- 
mediated IL-8 and MCP-1 production were evaluated in SMC pretreated with inhibitors 
of PTK and PKC activiQr. SMC were treated either with herbimycin A, a potent, broad 
PTK inhibitor, or H-7, an inhibitor of PKC, prior to CD40 stimulation. The inhibitors 
were used at concentrations based on previous experiments (Suttles and others 1996), 
and caution was exercised to ensure that the concentrations used did not affect cell 
viabiliQr and total protein synthesis. Stimulus was provided by plasma membranes 
purified from CD4^ T cells which had been activated for 6 hours (a time point at which 
CD 154 expression was optimal) as well as by co-culture of SMC with CD 154 
transfectants, or the CD 154  ^Jurkat T cell variant, D l.l (Yellin and others 1991;
Yellin and others 1994). SMC were pretreated with or without 0.5 pg/ml HerbA and 
2 pg/ml H-7 for -18 hours and then stimulated through CD40 with plasma membranes 
from either activated (CD 154  ^) CD4^ T cells designated TmA or CD 154-transfected 
293 cells. Supematants were collected for analysis at 18 hours. Controls consisted of 
supematants from SMC stimulated with resting (CD 154 ) CD4^ T cells designated 
TmR or the 293 parent cell line. SMC EL-8 and MCP-1 synthesis was 
induced by co-culture with TmA and the CD 154 transfectants, but not by co-culture 
with TmR or the control 293 population. Furthermore both IL-8 and MCP-1 
production was suppressed by both HerbA and H-7 which suggests that both PTK and 
PKC activity is required for CD40-mediated activation of SMC IL-8 and MCP-1
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production (Figure 9). Additionally, we demonstrated that activation of SMC induced 
by co-incubation with CD154 transfectants is inhibited by the addition of anti-CD 154 
antibodies confirming that the primary activating component of this interaction is the 
CD40 ligand, CD154 (Figure 10). These data suggest that CD40-mediated IL-8 and 
MCP-1 synthesis in SMC is a CD40-mediated event and dependent on both PTK and 
PKC activity.
CD40 Signaling in SMC results in Cvtokine and Chemokine mRNA Svnthesis 
SMC have the capacity to play an active role in vascular inflammation by their 
ability to produce a variety of cytokines including IL-1, TNF-a, IL-6, GM-CSF, IL-8, 
MCP-1, and monocyte chemotatic and activation factor (MCAF) (Ross 1993). The 
production of these cytokines by SMC may contribute to the recruitment and activation 
of leukocyte populations, resulting in vascular inflammation and plaque formation.
Since we observed that CD40 signaling in SMC resulted in the induction of the 
inflammatory chemokine synthesis, we next addressed the question how specific is 
CD40-mediated chemokine and cytokine synthesis in SMC. To address this question 
SMC were stimulated with TmA for various time points, and the mRNA was extracted 
and evaluated for a panel of inflammatory cytokines and chemokines by an RNAse 
protection assay as described in materials and methods. We previously observed that 
PTK, PKC, MEK/ERK and p38 were involved in CD40-mediated induction of IL-8 and 
MCP-1 in SMC, therefore we hypothesized that activation of these kinases had an effect 
on CD40-mediated cytokine/chemokine mRNA synthesis. To determine the
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Figure 9. Requirement for PTK and PKC Activity in CD40-Mediated SMC IL-8 
and MCP-1 Synthesis. SMC were pretreated with the PTK inhibitor, HerbA 
(0.5^g/ml) or the PKC inhibitor H-7 (2^g/ml) for 18 hours. SMC were either 
stimulated with 293-CD154 cells or the control parent 293 cell line. After 18 hours 
stimulation, supematants were removed and analyzed by ELISA.
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Figure 10. IL-8 Production by SMC is a CD40-Mediated Event. SMC were left 
unstimulated (control) or stimulated for 18 hours with 293 parent cell, CD 154 
transfectants, or CD 154 transfectants + antibody, as indicated. Supernatants were 
assayed for lL-8 production by ELISA.
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involvement of PTK, PKC, ERKl/2 and p38 activiQr in CEMO-mediated induction of 
cytokine/chemokine mRNA synthesis, SMC were pretreated with or without the PTK 
inhibitor. Herb A, the PKC inhibitor H-7, the MEK/ERK inhibitor PD98059, and the 
p38 inhibitor SB203S80, and stimulated at several time points with TmA (figure 11). 
Synthesis of TGPp-l, lL-8 and IL-IRA was observed with SMC stimulated with TmA. 
Inhibition of the cytokines/chemokines was seen with PD98059, SB203580 and HerbA 
treatment, but not with H-7. These data indicate that CD40 signaling in SMC results in 
the induction of cytokine/chemokine mRNA synthesis, and that activation of the 
MEK/ERK, p38 and possibly other pathways are involved.
CD40 Activation of ERKl/2 and p38 in SMC
Previous studies firom our laboratory demonstrated that CD40 signaling in 
monocytes is dependent on the activation of the ERKl/2 MAPK family members 
(Suttles and others 1999). In contrast, in B cells previous research has shown that 
CD40 signaling involves activation of the MAPK family members INK, p38 and 
ERKl/2 (Swantek and others 1997; Sanghera and others 1996). We next addressed the 
question are the MAPK signaling pathway(s) activated in response to CD40 ligation in 
SMC. All three MAPK family members; ERKl/2, p38 and INK were considered as 
candidates. To evaluate the ability of CD40 stimulation to activate the MAPK family 
members, SMC were treated with TmA or TmR over a 2 hour time period post­
activation. After a 10 to 120 minute incubation period, cell lysates were harvested and 
analyzed for MAPK activation by Western blot using antibodies specific for the
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Figure 11. CD40 Activation of Cytokine/Chemokine mRNA. SMC were left 
unstimulated or stimulated with TmA for 3, 6, or 19 hours in the absence or presence 
of 30mM PD98059, 30mM SB203S80, 0.5mg/ml HerbA, or 2mg/ml H-7. Lanel, 
unstimulated; lane2, TmA 3hour; lane 3, TmA 6 hour; lane 4, TmA 19 hours; lane 5, 3 
hour TmA + HerbA; lane 6, 6 hour TmA + HerbA; lane 7, 6 hour TmA + H-7; lane 
8, 6 hour TmA + PD98059; lane 9, 6 hour TmA 4- SB203S80.
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phosphorylated (active) fonns of ERKl/2, p38, and JNK. ERKl/2 and p38 
phosphorylation was evident at 10 minutes and declined at 2 hours (Figure 12A and B). 
Treatment of SMC with TmA over the same 2 hour time period examined did not 
induce JNK phosphorylation (Figure 12C). Probing the blot with antibody recognizing 
the nonphosphorylated forms of JNK present revealed that the absence of 
phosphorylated JNK present was not due to artiActs of gel loading (data not shown). 
Lysates from UV-treated 293 cells (New England Biolabs) were used as a positive 
control for anti-phospho-JNK reactive proteins.
CD40-Mediated lL-8 and MCP-1 Svnthesis in SMC is Dependent Upon ERKl/2 and 
p38 MAPK Activitv
Since both ERKl/2 and p38 MAPK family members appear to be involved in CD40 
signaling in SMC we next wanted to determine if the activation of ERKl/2 and p38 
MAPKs have a functional significance in CD40-mediated induction of lL-8 and MCP-1 
synthesis. The role of CD40-mediated activation of ERKl/2 and p38 in the induction 
of inflammatory chemokine synthesis was explored via upstream blockade of the 
ERKl/2 and p38 pathways. Activation of ERKl/2 is catalyzed by MEKl/2, which, 
itself, is activated through serine phosphorylation catalyzed by Raf family kinases 
(Davis 1993). Use of a specific MEKl/2 inhibitor, PD98059, which prevents Raf- 
mediated activation of MEKl/2 (Allessi and others 1995), (Figure 3), allowed us to 
evaluate the role of the MEK/ERK pathway in CD40-mediated induction of SMC lL-8 
and MCP-1 synthesis. Additionally, use of a specific p38 inhibitor, SB203580, (Figure
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Figure 12. CD40-Mediated Activation of ERKl/2 and p38 MAPK Family Members in 
SMC. SMC were either left unstimulated (control) or stimulated with LPS for 30 
minutes, or TmA for 10, 30, 60 or 120 minutes as indicated. Cell lysates were then 
harvested and analyzed by Western Blot with antibodies recognizing the phosphorylated 
form of A, ERKl/2; B, p38; and C, JNK.
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3), allowed us to evaluate the role of the p38 signaling pathway in CD40-mediated 
induction of SMC IL-8 and MCP-1. The influence of PD98059 and SB203S80 on 
CD40-mediated SMC lL-8 and MCP-1 synthesis was analyzed by enzyme-linked 
immunosorbant assay of SMC supemantants. SMC were stimulated for 18 hours by 
CD 154-transfected 293 cells (293-CD154) in the presence or absence of PD98059 and 
SB203580. Supernatants were then collected for analysis. Controls consisted of 
supernatants from SMC stimulated with the 293 parent cell line. SMC lL-8 and MCP-1 
synthesis was induced in response to stimulation with the 293-CD154 cells, but not with 
the control 293 parent line. Additionally IL-8 and MCP-1 synthesis was suppressed by 
the addition of PD98059 and SB203580 (Figure 13A and B), and had no adverse efrects 
on cell viabiliQr in a concentration range of l-lOOpM tested. These data suggest that 
MEK activation of ERKl/2 and the activation of p38 are critical elements 
in the signaling pathways of CD40-mediated induction of SMC lL-8 and MCP-1 
synthesis.
CD40 Signaling in SMC Results in Activation of the Transcription Factor NF-kB 
The transcription factor NF-kB is in part critical for gene expression of many 
cellular products involved in inflammatory responses, such as TNF-a, IL-ip, lL-6, IL- 
8 and MCP-1 (Sharma and others 1998). Previous observations have shown that 
CD40-mediated lL-8 and MCP-1 require activation of ERKl/2 and p38, we 
hypothesized that CD40 signaling in SMC results in activation of NF-kB and that 
activation of both ERKl/2 and p38 is required. To determine the role of CD40
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Figure 13. Requirement for ERKl/2 and p38 Activity in CD40-Mediated SMC IL-8 
and MCP-1 Synthesis. SMC were left untreated (control) or stimulated with TmA in 
the presence or absence of the MEK/ERK inhibitor PD980S9 or the p38 inhibitor 
SB203S80. After 18 hours supernatants were harvested and analyzed by ELISA for: A, 
IL-8 production or B, MCP-1 production.
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signaling in the activation o f transcription factors contributing to inflammatory cytokine 
and chemokine synthesis in SMC, nuclear localization of NF-kB was evaluated by 
electrophoretic mobilier shift assay (EMSA) as described in materials and methods. 
Additionally, the involvement of the MAPK family members ERKl/2 and p38 in 
CD40-mediated activation of NF-kB was examined. SMC were pretreated with or 
without the MEK/ERK inhibitor PD980S9 and the p38 inhibitor, SB203S80, and 
stimulated with TmA for 30 minutes. NF-kB was activated in SMC cells stimulated 
with TmA, and the amount of activation was decreased in cells pretreated with 
PD98059 and SB203580 (figure 14). These data suggest that CD40 signaling in SMC 
results in the activation and/or nuclear localization of the transcription factor NF-kB, 
and that the activation of the MEK/ERK and p38 pathways are critical.
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Figurel. CD40-Mediated Activation of NF-kB in SMC. SMC were left unstimulated 
(control) or stimulated with Img/ml TmA for 30 minutes in the absence or presence of 
30mM SB203580 or PD98059. Cells were then lysed and nuclear proteins extracted 
and an EMSA was performed for NF-kB activation. Band densities were determined 
by scanning densitometry. Lanel, unstimulated,; lane 2, Tm; lane 3, TmA + 
SB203580; lane 4, TmA + PD98059; lane 5, cold competition assay of 30 minute 
TmA stimulation; lane 6, positive control; lane 7, mutant oligo.
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CHAPTER 4 
DISCUSSION
The interaction of CD40 with its natural ligand CD 154 contributes to normal cell- 
mediated responses as well as to chronic inflammatory diseases (Stout and Suttles
1996). Atherosclerosis, or vascular inflammation is characterized by the migration of 
immune cells (i.e. monocytes, T cells) to the site of injury, which transmigrate through 
the endothelium from the media to the intima of an artery. There are many cells which 
contribute to the development of the disease, however the presence of activated,
CD 154^ T cells at these atherosclerotic lesions may play a crucial role in the 
maintenance and/or exacerbation of inflammation. There are several known functional 
attributes acquired in response to CD40 ligation in monocytes/macrophages including 
the up-regulation of inflammatory mediators, and the increase of monocyte/macrophage 
longevity, both events contributing to the maintenance and/or exacerbation of 
inflammatory disease. Studies of tissue sections of atherosclerotic plaques have found 
the accumulation of activated (CD154^), CD4^ T lymphocytes (Mach and others 1997) 
which have the capacity to interact with CD40 expressing cells in the vasculature 
including endothelial, monocytes/macrophages, and smooth muscle cells. Previous 
research has shown that both monocytes/macrophages and SMC have the ability to 
contribute to vascular inflammation by the production of inflammatory 
cytokines/chemokines, tissue factor, the up-regulation of adhesion molecules, and both
46
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have the propensi^ to become lipid-laden foam cells (Poe and others 1997; Mach and 
others 1997), In vascular inflammation the role of CD40, and the interactions that occur 
between major cell Qrpes contributing the formation of atherosclerotic plaques is 
currently under investigation. Experiments described in this dissertation were 
performed to determine the role of CD40 signaling in monocytes and SMC in the 
development of atherosclerosis. We examined the functional attributes acquired by 
SMC in response to CD40 ligation, and the role of MAPK signaling pathways activated 
in response to CD40 signaling in both monocytes and SMC.
Previous research done in our laboratory investigated the signaling pathways 
activated in response to CD40 ligation in monocytes resulting in the production of 
inflammatory cytokine synthesis. These studies revealed that the activation of PTK is a 
critical component in CD40-mediated activation of monocyte inflammatory cytokine 
synthesis, as well as rescue from apoptosis (Poe and others 1998). We evaluated the 
role of the MAPK family members as potential downstream mediators of CD40 
signaling in monocytes and SMC. MAPK ftunily members ERKl/2, p38 and JNK were 
all considered as likely candidates since previous reports have demonstrated that all 
three members are activated in response to CD40 signaling in B cells, and in LPS 
activation of monocytes (Li and others 1996; Sakata and others 1995; Sanghera and 
others 1996). The experiments presented in this dissertation employed primary human 
monocytes and primary aortic smooth muscle cells (of less than passage 6). Stimulus 
used in these studies included plasma membranes purified from activated (CD 154^) 
CD4^ T cells and CD 154 transfectants.
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We observed CD40 signaling in monocytes resulted in the rapid phosphorylation 
and activation of the MAPK ftunily member, ERKl/2, however over the same time 
period of stimulation, phosphorylation of p38 and JNK was not increased above 
background (Figure 4). Additionally, CD40-mediated activation of ERKl/2 in 
monocytes was accompanied by enhanced kinase activi^ and is a critical event in 
CD40-mediated monocyte IL-ip and TNFd synthesis (Suttles and others 1999). How 
ERKl/2 contributes to the transcriptional control of CD40-mediated induction of 
inflammatory cytokine synthesis is currently being investigated. Both IL-ip and TNFa 
genes are, in part, regulated by several transcription factors including NF-tcB and NF- 
IL-6. NF-IL-6 is a direct substrate of ERKl/2 catalytic activity.
The intent of our research is not only to determine how CD40 signaling in 
monocytes results in the activation of inflammatory cytokine synthesis, thus leading to 
inflammatory diseases such as vascular inflammation, rheumatoid arthritis, multiple 
sclerosis, and inflammatory bowel disease, but also in how to suppress the 
inflammatory process. Previous studies suggested that the anti-inflammatory cytokines 
IL-4 and IL-10 inhibited CD40-induced monocyte PTK activity, and CD40-mediated 
monocyte IL-ip production and together worked in a synergistic manner. Additionally, 
inhibition of CD40-mediated IL-ip synthesis, and activation of ERKl/2 in monocytes 
was observed in response to pretreatment with an PTK inhibitor suggesting that PTKs 
were a critical element in the monocyte CD40 signaling pathway (Poe and others
1997). IL-4 and IL-10 were evaluated for their ability to suppress CD40-mediated 
activation of ERKl/2 in monocytes. Both IL-4 and IL-10 modulated CD40-mediated
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ERKl/2 phosphorylation in monocytes, suggesting that the MAPK, ERKl/2 may be 
their target of inhibition (Figure S). Both IL-4 and IL-10 signal through receptors 
which associate with and activate Jaks upon ligation (O’Shea 1997; Leonard and 
O’Shea 1998). The Jaks in turn, activate the Stats which induce negative regulators of 
cytokine signaling SOCS, which work as a negative feedback system to inhibit the Jaks 
either directly or non-directly (Darnell 1997; Nicholson and Hilton 1998). IL-4 and IL- 
10 appear to act early in the signaling cascade since they inhibit PTK activity in CD40- 
mediated activation of monocyte inflammatory cytokine synthesis (Poe and others
1998). These data suggest that IL-4 and IL-10 may induce tyrosine phosphatase 
activity, resulting in the suppression of the CD40 signaling pathway in monocytes, and 
thus suppression of ERKl/2 activity.
Recent reports have shown that vascular inflammation involves the participation of 
immune competent cells and the activation of inflammatory pathways and mediators. 
Both monocytes and SMC are present at atherosclerotic plaques and may be the major 
progenitors of vascular inflammation (Mach and others 1997). We observed that SMC 
express CD40 (Figure 6) and other receptors that interact with T cells, similar to the 
monocytes including cell surftice expression of CD95 (Figure 7), intercellular adhesion 
molecule (ICAM), the costimulatory molecules B7-1(CD80) and B7-2 (CD86) (data not 
shown), and both have the ability to present antigen to CD4^ T cells (Suttles and others 
1994). These data suggest that CD40 signaling in SMC results in the activation of 
signaling pathways and induction of inflammatory mediators in a manner similar to 
what occurs in monocytes.
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The induction of chemokine synthesis may play an crucial role in the pathogenesis of 
atherosclerosis by promoting directed migration of immune competent cells to the site 
of injury. The observation that CD40 ligation in SMC induced the inflammatory 
chemokines MCP-1 and IL-8 suggested that SMC may play a critical role in the 
pathogenesis of atherosclerosis by enhancing the migration of immune competent cells 
to the atherosclerotic plaque. We further confirmed that the production MCP-1 and IL- 
8 was a CD40-mediated event by employing anti-CD 154 antibodies and blocking the 
synthesis of the chemokines as compared to treatment with an isotype control antibody 
(Figure 10). Furthermore, we observed that CD40-mediated induction of MCP-1 and 
IL-8 synthesis was partially dependent on both PTK and PKC activity (Figure 9), 
suggesting that the CD40 signaling pathway in SMC may also have similarities to the 
signaling pathway(s) activated in B cells in response to CD40 ligation. MCP-1 induces 
tissue factor (TF), a transmembrane glycoprotein that initiates coagulation, mRNA 
synthesis in SMC (Schecter and others 1997). The exposure of TF during plaque 
rupture may induce acute thrombosis resulting in myocardial infarction. Further 
investigation of MCP-1 production and its effects on SMC may lead to a greater 
understanding of the pathways involved and provide important targest for inhibition of 
vascular inflanunation and plaque thrombosis. The observation that CD40- 
mediated IL-8 and MCP-1 synthesis was, in part, dependent on PKC activity suggests 
that the PKC signaling pathway may play an important role in contributing to vascular 
inflammation and may be a potential target for modulation.
We observed that CD40 signaling in SMC resulted in the phosphorylation of the
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
51
MAPK family members ERKl/2 and p38, however we did not see activation of JNK 
over the time course examined (Figure 12). The critical dependence of both ERKl/2 
and p38 activation on CD40-mediated EL-8 and MCP-1 were also important 
observations (Figure 13), suggesting that both pathways may contribute to the 
regulation of transcription factor activation resulting in the synthesis of these 
chemokines. These data suggMt that CD40-mediated activation of SMC chemokine 
synthesis implements a distinctly different signaling pathway from that in monocytes 
and B cells. The ability of the MEKl/2 inhibitor PD98059 and the p38 inhibitor 
SB203580 to inhibit CD40-mediated SMC chemokine synthesis suggests that both 
MAPK signaling pathways are involved in the downstream activation of transcription 
factors resulting in chemokine production. Both IL-8 and MCP-1 are in regulated by 
several transcription factors including NF-kB (Roebuck and others 1999). SMC 
stimulated with TmA resulted in the activation of the transcription factor NF-kB 
(Figure 14). Additionally we observed that inhibitors of the MEK/ERK and the p38 
signaling pathways suppressed activation of NF-kB suggesting that both of the MAPKs 
are involved in CD40-mediated activation of this transcription factor. Activation of 
NF-kB in collaboration with the transcription Actors NF-IL-6 (C/EBP) and AP I 
regulate both IL-8 and MCP-1 transcription in most cells (Sharma and others 1998). 
These data suggest that the CD40 signaling in SMC results in the activation of the 
MEK/ERK and p38 MAPK signaling pathways which in turn activate transcription 
factors leading to the synthesis of the chemotactic factors IL-8 and MCP-1 at 
atherosclerotic lesions. We have demonstrated that CD40-mediated induction of VSMC
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chemokine synthesis was in part regulated by PTK and PKC (Figure 9), this suggests 
that both of these pathways may be involved in activation of the MAPK pathways. 
Activation of PTK results in activation of ERKl/2, and activation of PKC may result in 
the activation of the MAPK p38.
Finally, these data suggest that monocytes/macrophages and SMC present at 
atherosclerotic lesions may be critical regulators of vascular inflammation. Both of 
these cells are capable of interacting with activated T cells through CD40:CD154 
receptor-ligand pair resulting in the synthesis of inflammatory mediators.
Accumulation of activated T cells and monocytes/macrophages at plaque formation sites 
and in the neointima, and the activation and proliferation of SMC contribute to the 
inflammatory reaction that takes place inside the plaques. The production of 
inflammatory cytokines including IL-ip and TNFa, and the secretion of chemotactic 
factors including IL-8 and MCP-1 facilitate aberrant migration of immune competent 
cells to that site. The delineation of the signaling pathways activated in response to 
CD40 signaling in monocytes and SMC will help us to gain a better understanding of 
the pathways activated resulting in the onset of inflammation, and will help us define 
targets of therapeutic intervention.
The ability of the Th2 cytokines IL-4 and IL-10 to abrogate CD40-mediated 
monocyte cytokine synthesis, and ERKl/2 phosphorylation suggests that there may be 
direct interaction between the Jak/Stat and ERKl/2 signaling pathways. However, 
significantly different to the observations in the monocyte system, neither IL-4 nor IL- 
10 suppress CD40-mediated SMC chemokine production or MAPK phosphorylation
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(data not shown).
Monocytes and SMC exhibit many similar characteristics, but are distinctly 
unique in signaling pathways implemented in response to CD40 ligation (Figure 15). 
CD40 signaling in monocytes results in the activation of the inflammatory cytokines IL- 
ip and TNFa, which are both critically dependent on the activation of the MEK/ERK 
pathway, and can be suppressed by the anti-inflammatory cytokines IL-4 and IL-10. 
CD40 signaling in SMC results in the synthesis of the chemotactic Actors IL-8 and 
MCP-1, which are both dependent on the activation of the MEK/ERK and p38 
pathways suggesting divergence in the signaling pathway. However, CD40 signaling in 
both monocytes and SMC may result in the activation of divergent signaling pathways 
but with the downstream outcome being the activation of transcription Actors which 
contribute to the production of inflammatory cytokines and chemokines.
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Figure 15. Summary of CD40-Mediated Signaling Events in Monocytes and SMC
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